ANKORS Nelson Weekly Drug Checking Report – October 4, 2021
This week at ANKORS we tested a large variety of down samples of varying colours. The fentanyl content of these samples was consistent with recent trends, at about 10%. What is more concerning, however, is that all of the down samples tested positive for benzodiazepines using benzodiazepine test strips.
When used with fentanyl or other opioids, benzodiazepines have synergistic effects. Down samples with benzodiazepines or their analogues can increase the chance of overdose, and often cause atypical overdose responses. Benzodiazepines do not respond to naloxone; therefore it is important to give breaths when responding to an atypical overdose. Please continue to encourage people who are using drugs to have their drugs checked, to start slow, and to refrain from using alone.
While drug checking can help reduce the risk of using drugs by allowing users to make better informed decisions, please recognize that the use of FTIR spectrometry and test strips has limitations. Notably, the FTIR cannot detect substances that are present in small amounts or substances that are absent from the reference database. No drug use is completely safe, and checking your drugs does not eliminate all risk.
ANKORS Nelson Weekly Drug Checking Report –...
On Wednesday this week, ANKORS set up a pop up OPS and testing site next to the United Church in Trail. It was successful for a first event, not only to help folks get their stuff tested and consume drugs in a safer environment, but also to connect together people involved with the opioid crisis […]Continue reading
Drug Checking Report for Interior Health –...
The percentage of opioids testing positive for benzodiazepines in the Interior Health region (38%, 21 of 55 samples) fell slightly from last month, however its hard to know if this is a trend. Etizolam, the most common benzo found in opioids may be missed by drug checking technologies so the true rate may be higher […]Continue reading